Orthofix grants options and RSUs to CP&BOO
Orthofix Medical Inc. reported that executive Lucas Vitale, its CP&BOO, acquired new equity awards.
Rhea-AI Filing Summary
Orthofix Medical Inc. reported that executive Lucas Vitale, its CP&BOO, acquired new equity awards. On March 3, 2026, he received 45,546 employee stock options and a separate grant of 19,186 shares of common stock in the form of restricted stock units.
The restricted stock units vest in three equal installments, with one-third of the shares vesting on each of the first, second, and third anniversaries of the grant date. Following these grants, Vitale directly holds 167,030 shares of common stock, including previously reported restricted stock units and shares acquired under Orthofix’s Stock Purchase Plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 64,732 shares
Grant/Award
2 txns
Insider
Vitale Lucas
Role
CP&BOO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (Right to Buy) | 45,546 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 19,186 | $0.00 | $0.00 |
Holdings After Transaction:
Employee Stock Option (Right to Buy) — 45,546 contracts (Direct);
Common Stock — 167,030 shares (Direct)
Footnotes (3)
- F1. Represents a grant of restricted stock units approved by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered thereby on the first, second and third anniversary of the Grant Date.
- F2. Includes 123,894 previously reported restricted stock units and an aggregate of 12,527 shares acquired under Orthofix's Stock Purchase Plan ("Orthofix's SPP") on 04/30/2025 and 10/31/2025. Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5), and share acquisitions under the plan are exempt from Section 16(b).
- F3. The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first, second and third anniversary of the Grant Date.
FAQ
What equity awards did Orthofix (OFIX) grant to Lucas Vitale?
Orthofix granted Lucas Vitale 45,546 employee stock options and 19,186 shares of common stock as restricted stock units. These awards were approved by the board’s Compensation and Talent Development Committee as part of his executive compensation package.
How do Lucas Vitale’s new restricted stock units at Orthofix (OFIX) vest?
The restricted stock units vest in three equal parts, with one-third of the covered shares vesting on each of the first, second, and third anniversaries of the grant date. This creates a multi‑year incentive for continued service at Orthofix.
What is Lucas Vitale’s Orthofix (OFIX) common stock ownership after these awards?
After the March 3, 2026 grants, Lucas Vitale directly owns 167,030 shares of Orthofix common stock. This total includes previously reported restricted stock units and 12,527 shares acquired under Orthofix’s Stock Purchase Plan in 2025.
What role does the Compensation and Talent Development Committee play at Orthofix (OFIX)?
Orthofix’s Compensation and Talent Development Committee administers the plan under which Lucas Vitale’s restricted stock units were granted. It approves equity awards to executives and sets vesting terms, aligning compensation with company objectives and long‑term performance incentives.
What is Orthofix’s Stock Purchase Plan (SPP) mentioned in the Form 4 for OFIX?
Orthofix’s Stock Purchase Plan is described as a “Stock Purchase Plan” under Rule 16b‑3(b)(5). Shares acquired under the SPP, including 12,527 shares held by Lucas Vitale, are exempt from Section 16(b) short‑swing profit rules, providing a compliant way for ongoing share accumulation.
AI-generated analysis. How Rhea-AI works. Not financial advice.
